Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis

相似書籍

• Randomized pharmacokinetic evaluation of different rifabutin doses in African HIV- infected tuberculosis patients on lopinavir/ritonavir-based antiretroviral therapy
  由: Naiker, Suhashni, et al.
  出版: (2014)
• Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
  由: Moultrie, Harry, et al.
  出版: (2015)
• The SLCO1B1 rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications
  由: Chigutsa, Emmanuel, et al.
  出版: (2011)
• Population pharmacokinetic drug–drug interaction pooled analysis of existing data for rifabutin and HIV PIs
  由: Hennig, Stefanie, et al.
  出版: (2016)
• Effect of Rifampin and Rifabutin on the Pharmacokinetics of Lersivirine and Effect of Lersivirine on the Pharmacokinetics of Rifabutin and 25-O-Desacetyl-Rifabutin in Healthy Subjects
  由: Vourvahis, Manoli, et al.
  出版: (2012)